sefh | grupos de trabajo · microsoft powerpoint - proyecto de trazabilidad anna farriols jornadas...

��

��

��

Hospital Universitari Vall d’Hebron ��

��

��

��

!��"�!��"� � �� #��#��

• Variabilidad de dosis para un mismo citostático

• Errores de dosis pueden tener consecuencias graves /fatales.

Toxicidad

Eficacia


��

�� !�� !�� " #��$�� %&� #�� #�'(� )�# �� " #��$�� %&� #�� #�'(� )�# �*&��$�# �� ))�+�,��) ��,)�(�*&��$�# �� ))�+�,��) ��,)�(--.�,�� .�,��

�'/��+� ��( ��*�,�� 0�'�(��

��


�$�� % �� "

��&'��(� ��)� ��

�$�� % �� "

��&'��(� ��)� ��

�'/��+� ��( ��*�,�� 0�'�(��

Hospital Universitari Vall d’Hebron

��

*�+,$!�+��$��-�./0/��"�1$��/23��$0��04�!53�

*�$*��!/23�,��4/3/��!/23��$�6�/4/+�$�7*/�

�+�*/��0��00��$.�+3

*�+,$!�+��$��-�./0/��"�1$��/23��$0��04�!53�

*�$*��!/23�,��4/3/��!/23��$�6�/4/+�$�7*/�

�+�*/��0��00��$.�+3


��

8��*$�/�+�$4�3�0)./�$4�3�0��$�!/�+��7�/!+��$��$�0��4�!/��50/�$��$�+3!+0+19��0��

��4�!/��!$3��0


�+0/!/��*$�/�+��+0/!/��*$�/�+��$4�3�0)./�$4�3�0��$��$4�3�0)./�$4�3�0��$�!/�+��!/�+��77�/!+��$��$�0��/!+��$��$�0��4�!/��4�!/��550/�$��$�0/�$��$�

+3!+0+1+3!+0+199��0��4�!/��0��4�!/��

!$3��0!$3��0

��

��0��0��

��4�!/��4�!/��550/�$��$�0/�$��$�+3!+0+1+3!+0+199��

� ��

�� (� ��(� �� (� :�(� :�� ;�� ;� �� <<

��

��*�,�� 0�'�(��

1

2

3


8��*$�/�+��$4�3�0)./�$4�3�0��$�!/�+��7�/!��$��$�0��4�!/��

��50/�$��$�+3!+0+19��0��4�!/��!$3��0

$�� &=� �� (�� >�� *� �� #�� (� ��


8��*$�/�+��$4�3�0)./�$4�3�0��$�!/�+��7�/!��$��$�0��4�!/��

��50/�$��$�+3!+0+19��0��4�!/��!$3��0


?��$!$*!/23��$0�*$�/�+

��


�� @��@� �'�� 0��4�!/��50/�$��$�

+3!+0+19�"�

�$�4/3�0��$�4�3+� �� &� ��

!��&� $�3�8A�;�� &�$�3�8?B>�% �� '��)� ��<

.

?��$!$*!/23��$0�*$�/�+�$3�0��4�!/��50/�$


$4.�0�C$��$!�3��/+

� ,1�� 2��1� �� (�� 2 ��1�� ,1��) 34� ,-��.� �� '��#� �� 2�� 34 �5��6 �� 5�6 �� !�� 2��6 �� 7�� 8886 �� 9��"�� 5��1�� " �� :�� 5�� )� �),(&*� (�� ;�'��,�,�-)<;�,=� ,��&,��

$4.�0�C$�*�/4��/+

� #� ��"�6 �� 5��6 �� 6 �� 6 2�� 6 95 �� 1� " �� 7�� 6 9��

� $�� 9�� " �� 1��

?��$!$*!/23��$0�*$�/�+�$3�0��4�!/��50/�$


?��$!$*!/23��$0�*$�/�+�$3�0��4�!/��50/�$


� �� 1� �� ;�� 1�� ) 34 !�� " �� >� �� &� 9�� 6 �� 6 � 2�� " �� #� �� (��6 �� (��# ��2��

?��$!$*!/23��$0�*$�/�+�$3�0��4�!/��50/�$


��1� �� *+��0+�$��

D �� '�� !��&�� % �� @� �� '�� &�

$�3�8?B

?��$!$*!/23��$0�*$�/�+�$3�0��4�!/��50/�$


� ?,�� !��@

� ?��!�� >� ��@ ?�� @

� ?��!�� @ ��1� �� (��#�

��

?��$!$*!/23��$0�*$�/�+�$3�0��4�!/��50/�$


$��% �� )�:��% ��

(� ��

+ &�� 3��E�@��&=��% ��

��

+�)��/�# � �),�)+�)��)��#

?��$!$*!/23��$0�*$�/�+�$3�0��4�!/��50/�$


A�� (� �� (� :� �� ;� ��

��<

��


� ��

� �� #�� 6 ��

A�� (� �� (� :� �� ;� �� <


� #� �� 1�� ) 34 !�� " �� >� �� A�� 1� �� B��$�)�( �� $�)�CD�

� &� 9�� 6 �� 2�� (��<(��# !�� !��

� ;�� 9�� !�� 6 �� 2�� 6 �� 2�� " �� 1�6 �� " 2��

A�� (� �� (� :� �� ;� �� <


��

F��*�$*��!/23��$�.�3�$C��/3�/�/��0/-��*+��*�!/$3�$


��1� �� 1� ��9��

F��*�$*��!/23��$�.�3�$C��/3�/�/��0/-��*+��*�!/$3�$�


G��/3�$��!$

��


G��/3�$��!$

��2�� 1� �� 1�� 1� �� %�


��

H��.�/!�!/23


H��.�/!�!/23��&'��+-

��

,�� E�F;�F �� E��G �� F ��


H��.�/!�!/23��&'��+-


� H��.�/!�!/23��&'��+-

H��.�/!�!/23��&'��+-


H��.�/!�!/23��&'��+-


�� !"#$%$& ��!"#$%$& ��!"#$%$& ��!"#$%$&''''(�)!�%(�*��(�)!�%(�*��(�)!�%(�*��(�)!�%(�*��


H��.�/!�!/23��&'��+-


H��.�/!�!/23��&'��+-

Nombre paciente


��


H��.�/!�!/23�

.��1� �� !�� 1�� !�� "� �� 2��1� �� 1� %�


H��.�/!�!/23�


RESTOS


H��.�/!�!/23��!�� !��3�/��/�+


,�� 9��

� ��(� �� ;��<1��3�/-��0��+�/��*�$*��

H��.�/!�!/23��!�� !��3�/��/�+


�� !�� !�� " 9�� #� �� " 9�� #� ��

H��.�/!�!/23��!�� !��3�/��/�+


H��.�/!�!/23��!�� !��3�/��/�+


H��.�/!�!/23��!�� !��3�/��/�+"��$!+3��/��!/23


� (�� (�� 2 ��1� �� 9�� A� �>� ��D �� A�� 2�� 5�� D� ��2��1� 9��

� �� :�� 2��9�� >� �� A)� #� ��#��)� �� ,-��.� �� '��# ��) 3HI �) �( �$'�(�/� ��$�� * �) $&,=�# �,�#��)�# )� #�%&�� ( ��) 346 %&� ��)��;�,��J� ��&,�� )� (�� )� ,��&,��D

��

!+3��+0�!��0/��/�+"�

H��.�/!�!/23��!�� !��0/��/�+


H��.�/!�!/23��!�� !��0/��/�+


H��.�/!�!/23��!�� !��0/��/�+

,�� ,�� 9�� 9�� 11� � ��6 �� 6 �� 9� �� 6 �� 6 �� 9� �� A�� A�� D�� D


� VENTAJAS SISTEMA VOCOLLECT (sistemas dirigidos por reconocimiento de voz)

• #� 2�� 1�� 1� 9��

• ,�� 9��6 �� >� �� 1� �� 2�� A�� 1� �� D�

H��.�/!�!/23��&'��+-


+�:��"�+�:��"�� 11� !�� !�� 9�� 955� �� 11� ��


� INCONVENIENTES SISTEMA VOCOLLECT

• �� A��D�

• ;�� >� �� 9�� (�� >� ��

•�� " �� 9��

H��.�/!�!/23��&'��+-


H��.�/!�!/23��&'��+-


�$+$,-.("-�$+$,-.("-�$+$,-.("-�$+$,-.("-////####

F,"��,��A�� =�� " �� .��2��D6

F��9K A�� =�� #"�� " �� 7$�� #�D

F�� A�� (��D

$&,=�# .��,��#

sefh | grupos de trabajo · microsoft powerpoint - proyecto de trazabilidad anna farriols jornadas...

Documents